Skip to main content
Clinical Trials/NCT02010723
NCT02010723
Completed
Phase 4

Comparison of Surgery Versus Foam Sclerotherapy for Isolated Accessory Great Saphenous Vein Varicosis

Medical University of Vienna1 site in 1 country40 target enrollmentJune 2006

Overview

Phase
Phase 4
Intervention
surgery
Conditions
Varicose Veins
Sponsor
Medical University of Vienna
Enrollment
40
Locations
1
Primary Endpoint
duplex-sonographic recurrence after 3 years
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to compare two therapeutic procedures in the treatment of isolated varicosis of the anterior accessory great saphenous vein (AAGSV): crossectomy and avulsion of the varicose AAGSV versus foam sclerotherapy of the AAGSV.

Registry
clinicaltrials.gov
Start Date
June 2006
End Date
February 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kornelia Boehler

MD

Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • reflux in anterior accessory great saphenous vein (AAGSV) \> 0,5 sek

Exclusion Criteria

  • concomitant reflux in great saphenous vein (GSV)
  • reflux in the deep venous system (postthrombotic syndrome)
  • acute thrombosis
  • hypercoagulability
  • allergy to aethoxysclerol or local anesthetics
  • immobility
  • open foramen ovale
  • bacterial infection of the skin
  • pregnancy and breast feeding
  • peripheral arterial occlusive disease III, IV (PAOD)

Arms & Interventions

surgery

crossectomy and avulsion of the varicose anterior accessory great saphenous vein (AAGSV) under local anesthesia

Intervention: surgery

sclerotherapy

foam sclerotherapy with aethoxysclerol foam

Intervention: sclerotherapy with aethoxysclerol foam

Outcomes

Primary Outcomes

duplex-sonographic recurrence after 3 years

Time Frame: 3 years

duplex-sonographic recurrence is defined as reverse blood flow of \> 0.5 sec along the anterior accessory great saphenous vein (AAGSV) in the sclerotherapy group or in new anterior thigh varicosities connected to the previous saphenofemoral junction (NATV) in the surgical group.

Secondary Outcomes

  • neovascularisation in the saphenofemoral junction(1 year and 3 years)
  • duplex-sonographic recurrence after 1 year(1 year)
  • clinical recurrence(1 year and 3 years)

Study Sites (1)

Loading locations...

Similar Trials